Inventor profile of:

Jeffrey E. SETTLEMAN

City:

Newton, Massachusetts

Country:

United States

Published Applications:

11

Last publication date:

2023-07-20

Top Assignees for applications by Jeffrey E. SETTLEMAN

The entities that hold a legal rights for patent applications filed by inventor SETTLEMAN Jeffrey E.:

Recent patent applications by SETTLEMAN Jeffrey E.

Jeffrey E. SETTLEMAN from Newton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-07-20
US20230226039A1
Human necessities

METHOD FOR TREATING GEFITINIB RESISTANT CANCER

#2 | 2021-01-21
US20210017604A1
Chemistry; metallurgy

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

#3 | 2018-09-06
US20180251860A1
Chemistry; metallurgy

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

#4 | 2016-10-27
US20160310482A1
Human necessities

Method for treating gefitinib resistant cancer

#5 | 2015-06-25
US20150176081A1
Chemistry; metallurgy

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

#6 | 2013-11-28
US20130316935A1
Chemistry; metallurgy

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

#7 | 2010-04-08
US20100087482A1
Human necessities

Method for treating gefitinib resistant cancer

#8 | 2008-09-25
US20080234264A1
Chemistry; metallurgy

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

#9 | 2008-08-28
US20080207615A1
Chemistry; metallurgy

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

#10 | 2008-04-24
US20080096212A1
Chemistry; metallurgy

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

#11 | 2006-07-06
US20060147959A1
Chemistry; metallurgy

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

InventorID:

548852 ⎘